DWT
FATE icon

Dorsey & Whitney Trust’s Fate Therapeutics FATE Stock Holding History

Dorsey & Whitney Trust’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,500
Closed -$213K – 574
2022
Q3 		$213K Hold
9,500
– – 0.02% 491
2022
Q2 		$235K Buy
9,500
+4,200
+79% +$116K 0.02% 465
2022
Q1 		$205K Buy
+5,300
New +$205K 0.02% 534

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dorsey & Whitney Trust's FATE Position: Q4 2022 in Review

Dorsey & Whitney Trust sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 9,500 shares — an estimated $213K sold.

Dorsey & Whitney Trust first reported a position in FATE in Q1 2022 and held it in 3 quarters. The position peaked at $235K in Q2 2022. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • Dorsey & Whitney Trust reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 9,500 Fate Therapeutics shares in Q4 2022, an estimated $213K.
  • Dorsey & Whitney Trust first reported a position in Fate Therapeutics in Q1 2022 and held it in 3 quarters.
  • Dorsey & Whitney Trust's Fate Therapeutics position peaked at $235K in Q2 2022.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2022, filed 9 Feb 2023.